Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

Shahin Akhondzadeh,Raofeh Ghayyoumi,Farzin Rezaei,Bahman Salehi,Amirhossein Modabbernia,Azad Maroufi,Gholam Reza Esfandiari,Mehrangiz Naderi,Fariba Ghebleh,Mina Tabrizi,Shams-Ali Rezazadeh

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

2011

Shahin Akhondzadeh
Raofeh Ghayyoumi
Farzin Rezaei
Bahman Salehi
Amirhossein Modabbernia
Azad Maroufi
Gholam Reza Esfandiari
Mehrangiz Naderi
Fariba Ghebleh
Mina Tabrizi
Shams-Ali Rezazadeh

Rational It has been suggested that phosphodiesterase 5 inhibitors such as sildenafil may be effective in the treatment of negative symptoms of schizophrenia.

Keywords:

Randomized controlled trial
Anesthesia
Sildenafil
cGMP-specific phosphodiesterase type 5
Positive and Negative Syndrome Scale
Psychology
Schizophrenia
Placebo-controlled study
Phosphodiesterase
Risperidone
double blind
pharmacology toxicology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations